Skip to main content

Table 1 Patient specifics of the groups, such as sex, median age (min-max), diabetes, immunosuppression due to medication, peripheral arterial disease, malignant tumour, anticoagulation, and rheumatism, are presented

From: Silver-coated modular Megaendoprostheses in salvage revision arthroplasty after periimplant infection with extensive bone loss – a pilot study of 34 patients

 

Silver- coated group SCG)

non silver-coated Group (NSCG)

Statistical significance (α = 0.05)

Femal sex

55% (11/20)

57% (8/14)

0.91

Median Age (min-max)

74 (46–83)

69 (35–87)

0.36

Diabetes

45% (9/20)

42% (6/14)

0.91

Drug immunosuppression

5% (1/20)

7%(1/14)

0.80

Peripheral arterial disease, PAD

10% (2/20)

0

0.21

Malignomas

0

14% (2/14)

0.08

Anticoagulation

30%(6/20)

28%(4/14)

0.93

Rheumatism

5%(1/20)

7%(1/14)

0.85